HC Wainwright & Co. Maintains Buy on Geovax Labs, Adjusts Price Target To $120 (1-15 Reverse Stock Split)
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has maintained its Buy rating on Geovax Labs (NASDAQ:GOVX) and adjusted the price target to $120 from $8, reflecting a 1-15 reverse stock split.
June 18, 2024 | 5:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has maintained its Buy rating on Geovax Labs and adjusted the price target to $120 from $8, reflecting a 1-15 reverse stock split.
The maintenance of a Buy rating and a significant price target adjustment by HC Wainwright & Co. is a positive signal for investors. The 1-15 reverse stock split is likely to increase the stock price per share, making it more attractive to institutional investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100